BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20668230)

  • 1. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody.
    Cheong C; Choi JH; Vitale L; He LZ; Trumpfheller C; Bozzacco L; Do Y; Nchinda G; Park SH; Dandamudi DB; Shrestha E; Pack M; Lee HW; Keler T; Steinman RM; Park CG
    Blood; 2010 Nov; 116(19):3828-38. PubMed ID: 20668230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
    Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.
    Trumpfheller C; Finke JS; López CB; Moran TM; Moltedo B; Soares H; Huang Y; Schlesinger SJ; Park CG; Nussenzweig MC; Granelli-Piperno A; Steinman RM
    J Exp Med; 2006 Mar; 203(3):607-17. PubMed ID: 16505141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
    Ruane D; Do Y; Brane L; Garg A; Bozzacco L; Kraus T; Caskey M; Salazar A; Trumpheller C; Mehandru S
    Mucosal Immunol; 2016 Sep; 9(5):1340-52. PubMed ID: 26732678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of anti-human DEC205/CD205 monoclonal antibodies that recognize epitopes conserved in different mammals.
    Park CG; Rodriguez A; Ueta H; Lee H; Pack M; Matsuno K; Steinman RM
    J Immunol Methods; 2012 Mar; 377(1-2):15-22. PubMed ID: 22273672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
    BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice.
    Zhou J; Cheung AK; Tan Z; Wang H; Yu W; Du Y; Kang Y; Lu X; Liu L; Yuen KY; Chen Z
    J Clin Invest; 2013 Jun; 123(6):2629-42. PubMed ID: 23635778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
    Flynn BJ; Kastenmüller K; Wille-Reece U; Tomaras GD; Alam M; Lindsay RW; Salazar AM; Perdiguero B; Gomez CE; Wagner R; Esteban M; Park CG; Trumpfheller C; Keler T; Pantaleo G; Steinman RM; Seder R
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7131-6. PubMed ID: 21467219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC.
    Bozzacco L; Trumpfheller C; Huang Y; Longhi MP; Shimeliovich I; Schauer JD; Park CG; Steinman RM
    Eur J Immunol; 2010 Jan; 40(1):36-46. PubMed ID: 19830741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8
    Ngu LN; Nji NN; Ambada G; Ngoh AA; Njambe Priso GD; Tchadji JC; Lissom A; Magagoum SH; Sake CN; Tchouangueu TF; Chukwuma GO; Okoli AS; Sagnia B; Chukwuanukwu R; Tebit DM; Esimone CO; Waffo AB; Park CG; Überla K; Nchinda GW
    Immun Inflamm Dis; 2018 Mar; 6(1):163-175. PubMed ID: 29205929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes.
    Bozzacco L; Trumpfheller C; Siegal FP; Mehandru S; Markowitz M; Carrington M; Nussenzweig MC; Piperno AG; Steinman RM
    Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1289-94. PubMed ID: 17229838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
    J Virol; 2017 May; 91(9):. PubMed ID: 28202751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PE-Cy5.5 conjugates bind to the cells expressing mouse DEC205/CD205.
    Park CG; Rodriguez A; Steinman RM
    J Immunol Methods; 2012 Oct; 384(1-2):184-90. PubMed ID: 22841832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen Delivery to DEC205
    Silva MO; Almeida BS; Sales NS; Diniz MO; Aps LRMM; Rodrigues KB; Silva JR; Moreno ACR; Porchia BFMM; Sulczewski FB; Boscardin SB; Ferreira LCS
    Int J Biol Sci; 2021; 17(11):2944-2956. PubMed ID: 34345218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
    Niezold T; Storcksdieck Genannt Bonsmann M; Maaske A; Temchura V; Heinecke V; Hannaman D; Buer J; Ehrhardt C; Hansen W; Überla K; Tenbusch M
    Immunology; 2015 Aug; 145(4):519-33. PubMed ID: 25819746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4
    Ngu LN; Nji NN; Ambada GE; Sagnia B; Sake CN; Tchadji JC; Njambe Priso GD; Lissom A; Tchouangueu TF; Manga Tebit D; Waffo AB; Park CG; Steinman RM; Überla K; Nchinda GW
    Immun Inflamm Dis; 2019 Jun; 7(2):55-67. PubMed ID: 28474788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes.
    Swee LK; Guimaraes CP; Sehrawat S; Spooner E; Barrasa MI; Ploegh HL
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1428-33. PubMed ID: 23297227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo.
    Flamar AL; Contreras V; Zurawski S; Montes M; Dereuddre-Bosquet N; Martinon F; Banchereau J; Le Grand R; Zurawski G; Levy Y
    PLoS One; 2015; 10(9):e0135513. PubMed ID: 26407317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
    Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
    Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.